Today, XSML, the fund manager active in Central Africa, announced the investment of its African Rivers Fund (ARF) in B.I.S., a Congolese manufacturer of generic pharmaceutical products. For over 20 years, B.I.S. has been producing and marketing tested solutions to prevent and cure infections to ears, eyes and throat, for the local market.
News By Category: Healthcare
Today, Dutch fund manager XSML announced the final close of its Central Africa SME Fund (CASF). With increased commitments from two of its existing investors, FMO and Lundin Foundation, the fund reached a final close of USD 19 million.